Kwame Osei

4.0k total citations
108 papers, 2.9k citations indexed

About

Kwame Osei is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Kwame Osei has authored 108 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Kwame Osei's work include Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Diabetes Management and Research (27 papers) and Metabolism, Diabetes, and Cancer (20 papers). Kwame Osei is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Diabetes Management and Research (27 papers) and Metabolism, Diabetes, and Cancer (20 papers). Kwame Osei collaborates with scholars based in United States, Ghana and Greece. Kwame Osei's co-authors include Trudy Gaillard, Dara P. Schuster, Dara Schuster, Ronald M. Ferguson, Mitchell L. Henry, James M. Falko, Fernando G. Cosio, Todd E. Pesavento, Thomas M. O’Dorisio and Kathleen Dungan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Kwame Osei

105 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kwame Osei United States 31 1.6k 750 632 496 494 108 2.9k
Rüdiger Landgraf Germany 20 1.3k 0.8× 454 0.6× 248 0.4× 291 0.6× 314 0.6× 101 2.2k
Hilla Knobler Israel 25 815 0.5× 367 0.5× 948 1.5× 405 0.8× 181 0.4× 61 2.7k
Sandra Pinho Silveiro Brazil 24 965 0.6× 515 0.7× 300 0.5× 443 0.9× 242 0.5× 91 3.0k
Tahseen A Chowdhury United Kingdom 27 864 0.5× 397 0.5× 240 0.4× 434 0.9× 155 0.3× 132 2.3k
Paul F. Williams Australia 29 502 0.3× 603 0.8× 282 0.4× 622 1.3× 132 0.3× 89 2.6k
Johan Wadén Finland 32 1.7k 1.0× 475 0.6× 369 0.6× 285 0.6× 613 1.2× 50 3.2k
Shikha S. Sundaram United States 26 761 0.5× 1.1k 1.4× 1.4k 2.1× 236 0.5× 146 0.3× 72 2.9k
Valma Harjutsalo Finland 35 2.1k 1.3× 923 1.2× 363 0.6× 376 0.8× 1.3k 2.7× 137 3.9k
Agnès Pascot Canada 21 1.3k 0.8× 581 0.8× 845 1.3× 255 0.5× 114 0.2× 27 2.7k
So Hun Kim South Korea 23 483 0.3× 231 0.3× 504 0.8× 417 0.8× 165 0.3× 78 1.9k

Countries citing papers authored by Kwame Osei

Since Specialization
Citations

This map shows the geographic impact of Kwame Osei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwame Osei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwame Osei more than expected).

Fields of papers citing papers by Kwame Osei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kwame Osei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwame Osei. The network helps show where Kwame Osei may publish in the future.

Co-authorship network of co-authors of Kwame Osei

This figure shows the co-authorship network connecting the top 25 collaborators of Kwame Osei. A scholar is included among the top collaborators of Kwame Osei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kwame Osei. Kwame Osei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Wei, Qingxin Yuan, Bo Xu, Kwame Osei, & Jie Wang. (2016). Exenatide substantially improves proinsulin conversion and cell survival that augment Ins2 +/Akita beta cell function. Molecular and Cellular Endocrinology. 439. 297–307. 1 indexed citations
2.
3.
Dungan, Kathleen, et al.. (2014). A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbation. Diabetes/Metabolism Research and Reviews. 31(1). 93–101. 5 indexed citations
4.
Zhang, Xiaoping, Linda Degenstein, Yun Cao, et al.. (2012). β-Cells with Relative Low HIMP1 Overexpression Levels in a Transgenic Mouse Line Enhance Basal Insulin Production and Hypoxia/Hypoglycemia Tolerance. PLoS ONE. 7(3). e34126–e34126. 7 indexed citations
6.
Dungan, Kathleen, Kwame Osei, Haikady N. Nagaraja, Dara P. Schuster, & Philip F. Binkley. (2010). Relationship Between Glycemic Control and Readmission Rates in Patients Hospitalized With Congestive Heart Failure During Implementation of Hospital-Wide Initiatives. Endocrine Practice. 16(6). 945–951. 27 indexed citations
7.
Mount, David L., Patricia Feeney, Anthony N. Fabricatore, et al.. (2009). Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials. Clinical Trials. 6(5). 416–429. 5 indexed citations
8.
Gaillard, Trudy, Dara Schuster, & Kwame Osei. (2008). Independent role of blood pressure on cardiovascular risk factors in nondiabetic, obese African-American women with family history of type 2 diabetes: Implications for metabolic syndrome components. Journal of the American Society of Hypertension. 3(1). 25–34. 9 indexed citations
9.
Stakos, Dimitrios, Dara P. Schuster, Elizabeth Sparks, et al.. (2007). Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals with insulin resistance. European Journal of Endocrinology. 157(1). 63–68. 12 indexed citations
10.
Osei, Kwame, Trudy Gaillard, & Dara Schuster. (2005). Plasma Adiponectin Levels in High Risk African‐Americans with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Type 2 Diabetes**. Obesity Research. 13(1). 179–185. 39 indexed citations
12.
Osei, Kwame, Trudy Gaillard, June Kaplow, Matthew Bullock, & Dara Schuster. (2004). Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes. Metabolism. 53(12). 1552–1557. 40 indexed citations
13.
Stakos, Dimitrios, Dara P. Schuster, Elizabeth Sparks, et al.. (2003). Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.. PubMed. 41(4). 183–90. 8 indexed citations
14.
Amoah, Albert, Samuel Owusu, Dara P. Schuster, & Kwame Osei. (2002). Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.. PubMed. 92(5). 377–84. 22 indexed citations
15.
Schuster, Dara P., et al.. (1997). Do Sociodemographics and Economic Status Predict Risks for Type II Diabetes in African Americans?. The Diabetes Educator. 23(3). 294–300. 17 indexed citations
17.
Osei, Kwame & Dara P. Schuster. (1996). Decreased Insulin-Mediated but Not Non-Insulin-Dependent Glucose Disposal Rates in Glucose Intolerance and Type II Diabetes in African (Ghanaian) Immigrants. The American Journal of the Medical Sciences. 311(3). 113–121. 13 indexed citations
19.
Osei, Kwame. (1986). Chronic Hyponatremia Associated With Diabetic Amyotrophy. Archives of Internal Medicine. 146(3). 534–534. 1 indexed citations
20.
Falko, James M. & Kwame Osei. (1985). Combination insulin/glyburide therapy in type II diabetes mellitus. The American Journal of Medicine. 79(3). 92–101. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026